Šīs tīmekļa vietnes satura kvalitātes uzlabošanai un pielāgošanai lietotāju vajadzībām tiek lietotas sīkdatnes - tai skaitā arī trešo pušu sīkdatnes. Turpinot lietot šo vietni Jūs piekrītat sīkdatņu lietošanai.
Sales of Olainfarm Increase by 55% in January
Emitents Olainfarm, AS (213800WCG52W62ENOP27)
Veids Citi
Valoda EN
Statuss Publicēts
Versija
Datums 2013-02-15 17:02:08
Versijas komentārs
Teksts

Olaine, February 15, 2013

Sales of Olainfarm Increase by 55% in January

Preliminary consolidated results of AS “Olainfarm” for January 2013 show that sales have increased by 55% compared to the
same period of last year and have reached 5.47 million lats (7.78 million euros).  Major sales increases were achieved in
Belarus, where sales grew by 110%, Russia (by 105%) and Latvia, where sales grew by 48%.  Biggest sales markets of AS
“Olainfarm” in January 2013 were Russia, Latvia and Ukraine


January 2013, consolidated results  Share in total sales Changes to January 2012
Russia 50% 105%
Latvia 18% 48%
Ukraine 14% -22%
Belarus 7% 110%
UK 5% NA
Uzbekistan 2% NA
Czech Republic 1% NA
Italy <1% NA
Kazakhstan <1% NA
Moldova <1% NA
Other 1% -79%
Total 100% 55%

Sales of pharmacies owned by AS “Olainfarm” in January 2013 was 0.74 million lats (1.05 million euros).

According to preliminary unconsolidated results of AS “Olainfarm”, the sales during January 2013 were 4.92 million lats
(7 million euros), which represents an increase by 63% compared to similar period a year ago.  Most rapid sales increases
were achieved in Latvia (by 165%), Belarus (by 110%) and Russia, where sales grew by 105%. According to unconsolidated
results the main sales markets of AS “Olainfarm” in January 2013 were Russia, Ukraine, Latvia and Belarus.

January 2013, unconsolidated results Share in total sales Changes to January 2012
Russia 55% 105%
Ukraine 16% -22%
Latvia 9% 165%
Belarus 8% 110%
UK 6% NA
Uzbekistan 3% NA
Czech Republic 1% NA
Italy <1% NA
Kazakhstan <1% NA
Moldova <1% NA
Other 1% -79%
Total 100% 63%

Although no sales targets for 2013 are formally approved yet, for planning purposes management is using the target of 50
million lats (71.1 million euros) for unconsolidated sales and 57 million lats (81.1 million euros) for consolidated sales.
According to these preliminary results, during the month of January the company has made 9.8% of annual unconsolidated sales
target and 9.6% of annual consolidated sales target.


________________________________________ A/s Olainfarm is one of the biggest pharmaceutical companies in Latvia with 40 years
 of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's
operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by
the Group are being exported to more than 30 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia,
North America and Australia. 
Information prepared by:

   Salvis Lapins
   Member of the Board
   A/s „Olainfarm”
  Tel: +371 6 7013 717
e-mail: Salvis.Lapins@olainfarm.lv

 

Pielikumi